In late March, as Covid-19 forced educational institutions across the country to shut down most of their ongoing research activities, Rutgers announced the formation of a university hub known as the Covid-19 Center for Response and Pandemic Preparedness. Like the country’s other great research universities, Rutgers called on scientists across an array of its own institutions—including the Institute for Infectious and Inflammatory Diseases; the Institute for Translational Medicine and Science; Rutgers New Jersey Medical School; Rutgers Cancer Institute of New Jersey; and schools of pharmacy, public health, engineering, computational science, social sciences and others—to focus on learning more about SARS-CoV-2 and to develop treatments for the disease it causes. To read the full story.
Recent Posts
- Bioengineered Blood Vessels Show Promise in Trauma Care.
- New NJACTS Publication
- Study Finds Transfusing More Blood Reduces Risk of Death at Six Months in Heart-Attack Patients with Anemia.
- New NJACTS Publication
- Princeton researchers awarded NJ ACTS grant to study dendritic plasticity in neuropsychiatric disorders.
Categories
- Community (2,129)
- Covid (981)
- CTO Events (6)
- News (2,716)
- Pilots (21)